HeartFlow was founded in 2007 by Charles Taylor and Christopher Zarins. HeartFlow has not officially endorsed a plan to participate in an IPO.
HeartFlow is a biotechnology company with a mission to treat cardiovascular diseases through machine learning algorithms. Per Forge data, HeartFlow has raised a total of $792.7 million in funding over 11 rounds. Their latest funding was raised on Apr 6, 2023, from a Series F round. Key investors include Panorama Point Partners, Capricorn Investment Group, and Bain Capital Life Sciences.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/13/2019 | Series E | $305MM | $xx.xx | $1.65B | Wellington Management, Baillie Gifford | |
Price per Share
$xx.xx
Shares Outstanding
13,422,649
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Wellington Management, Baillie Gifford
|
||||||
05/10/2016 | Series D | $99.93MM | $xx.xx | $771.66MM | Panorama Point Partners, BlueCross BlueShield Venture Partners, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
7,151,873
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Panorama Point Partners, BlueCross BlueShield Venture Partners, undisclosed investors
|
||||||
02/26/2014 | Series C | $104.7MM | $xx.xx | $373.44MM | Sandbox Industries, HealthCor Management, Capricorn Investment Group, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
11,343,434
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sandbox Industries, HealthCor Management, Capricorn Investment Group, undisclosed investors
|
||||||
02/04/2011 | Series B-2 | $10.11MM | $xx.xx | $90.13MM | HealthCor Partners Management, GE Ventures, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
2,848,263
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
HealthCor Partners Management, GE Ventures, undisclosed investors
|
||||||
02/04/2011 | Series B-1 | $6.94MM | $xx.xx | $90.13MM | HealthCor Partners Management, GE Ventures, undisclosed investors | |
Price per Share
$xx.xx
Shares Outstanding
1,954,846
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
HealthCor Partners Management, GE Ventures, undisclosed investors
|
||||||
04/16/2010 | Series A | $2.04MM | $xx.xx | $8.17MM | Emergent Medical Partners, U.S. Venture Partners, BlueCross BlueShield Venture Partners, Capricorn Healthcare, Special Opportunities | |
Price per Share
$xx.xx
Shares Outstanding
4,082,965
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Emergent Medical Partners, U.S. Venture Partners, BlueCross BlueShield Venture Partners, Capricorn Healthcare, Special Opportunities
|